These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 15961276
21. Control of renin secretion from rat juxtaglomerular cells by cAMP-specific phosphodiesterases. Friis UG, Jensen BL, Sethi S, Andreasen D, Hansen PB, Skøtt O. Circ Res; 2002 May 17; 90(9):996-1003. PubMed ID: 12016266 [Abstract] [Full Text] [Related]
22. C(2)-ceramide influences the expression and insulin-mediated regulation of cyclic nucleotide phosphodiesterase 3B and lipolysis in 3T3-L1 adipocytes. Mei J, Holst LS, Landström TR, Holm C, Brindley D, Manganiello V, Degerman E. Diabetes; 2002 Mar 17; 51(3):631-7. PubMed ID: 11872660 [Abstract] [Full Text] [Related]
26. Suppression of insulin-stimulated phosphatidylinositol 3-kinase activity by the beta3-adrenoceptor agonist CL316243 in rat adipocytes. Ohsaka Y, Tokumitsu Y, Nomura Y. FEBS Lett; 1997 Feb 03; 402(2-3):246-50. PubMed ID: 9037204 [Abstract] [Full Text] [Related]
27. PKB inhibition prevents the stimulatory effect of insulin on glucose transport and protein translocation but not the antilipolytic effect in rat adipocytes. Smith U, Carvalho E, Mosialou E, Beguinot F, Formisano P, Rondinone C. Biochem Biophys Res Commun; 2000 Feb 16; 268(2):315-20. PubMed ID: 10679201 [Abstract] [Full Text] [Related]
28. Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes. Szkudelska K, Nogowski L, Szkudelski T. J Steroid Biochem Mol Biol; 2009 Jan 16; 113(1-2):17-24. PubMed ID: 19041941 [Abstract] [Full Text] [Related]
32. Altered phosphodiesterase 3-mediated cAMP hydrolysis contributes to a hypermotile phenotype in obese JCR:LA-cp rat aortic vascular smooth muscle cells: implications for diabetes-associated cardiovascular disease. Netherton SJ, Jimmo SL, Palmer D, Tilley DG, Dunkerley HA, Raymond DR, Russell JC, Absher PM, Sage EH, Vernon RB, Maurice DH. Diabetes; 2002 Apr 16; 51(4):1194-200. PubMed ID: 11916944 [Abstract] [Full Text] [Related]
33. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes. Verde I, Vandecasteele G, Lezoualc'h F, Fischmeister R. Br J Pharmacol; 1999 May 16; 127(1):65-74. PubMed ID: 10369457 [Abstract] [Full Text] [Related]
35. Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes. Xue B, Greenberg AG, Kraemer FB, Zemel MB. FASEB J; 2001 Nov 16; 15(13):2527-9. PubMed ID: 11641262 [Abstract] [Full Text] [Related]
36. Cyclic nucleotide phosphodiesterase 3B is a downstream target of protein kinase B and may be involved in regulation of effects of protein kinase B on thymidine incorporation in FDCP2 cells. Ahmad F, Cong LN, Stenson Holst L, Wang LM, Rahn Landstrom T, Pierce JH, Quon MJ, Degerman E, Manganiello VC. J Immunol; 2000 May 01; 164(9):4678-88. PubMed ID: 10779773 [Abstract] [Full Text] [Related]